Skip to main content

Calaspargase pegol-mknl

Details of the Drug
Generic Name:
Calaspargase pegol-mknl
kal-AS-par-jase PEG-ol mknl
Drug Type:
Asparagine specific enzyme
How the Drug is Given:


Calaspargase pegol-mknl

Indications and Usage

Calaspargase pegol-mknl is FDA approved as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia in pediatric and young adult patients age 1 month to 21 years. 


Side effects needing medical attention

The most common adverse reactions were elevated transaminase (a liver enzyme), bilirubin increased, pancreatitis and abnormal clotting.

For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.